Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Trial of NASHA Dx Urethral Bulking System

NCT: NCT07850804 · NOT_YET_RECRUITING

NCT IDNCT07850804
StatusNOT_YET_RECRUITING
Start Date2026-09
Completion2028-09
SponsorPalette Life Sciences, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

Prospective, randomized, single-blind study to evaluate the safety and efficacy of NASHA Dx investigational device compared to controlled device Bulkamid in adult women with mild, moderate and intrinsic sphincter deficiency (ISD).

Frequently Asked Questions

What is Trial of NASHA Dx Urethral Bulking System?

Trial of NASHA Dx Urethral Bulking System is a clinical trial registered under NCT07850804. Current status: NOT_YET_RECRUITING.

What is the status of NCT07850804?

The current status of NCT07850804 (Trial of NASHA Dx Urethral Bulking System) is: NOT_YET_RECRUITING.

When did Trial of NASHA Dx Urethral Bulking System start?

Trial of NASHA Dx Urethral Bulking System started on 2026-09.

Related Devices

K220641Barrigel Injectable GelPalette Life Sciences PMA P000029AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USEPalette Life Sciences PMA P100014AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USEPalette Life Sciences

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑